社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Ensysce Biosciences Inc.(ENSC)
盘后
0.5362
-0.01
-1.99%
16:25 EST
0.5471
+0.0082
+1.52%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
变盘时刻
·
02-27
走势还不错，0.68 MARK
$Ensysce Biosciences Inc.(ENSC)$
走势还不错，0.68 MARK$Ensysce Biosciences Inc.(ENSC)$
回复
评论
点赞
2
编组 21备份 2
分享
举报
Tingli
·
2025-05-14
$Ensysce Biosciences Inc.(ENSC)$
垃圾
$Ensysce Biosciences Inc.(ENSC)$ 垃圾
回复
评论
点赞
1
编组 21备份 2
分享
举报
Steven_Dai
·
2024-12-17
$Ensysce Biosciences Inc.(ENSC)$
搞起来啊
$Ensysce Biosciences Inc.(ENSC)$ 搞起来啊
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
笵纳德.不靠谱
·
2024-11-08
$Ensysce Biosciences Inc.(ENSC)$
艹，八毛进来挨毒打
$Ensysce Biosciences Inc.(ENSC)$ 艹，八毛进来挨毒打
回复
1
点赞
2
编组 21备份 2
分享
举报
笵纳德.不靠谱
·
2024-11-01
$Ensysce Biosciences Inc.(ENSC)$
是不是要完犊子了，74进来就这个样子
$Ensysce Biosciences Inc.(ENSC)$ 是不是要完犊子了，74进来就这个样子
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
我就赚一个小目标
·
2024-10-30
$Ensysce Biosciences Inc.(ENSC)$
又一支
$Bright Minds Biosciences Inc(DRUG)$
20倍股 50倍？你选吧
$Ensysce Biosciences Inc.(ENSC)$ 又一支$Bright Minds Biosciences Inc(DRUG)$ 20倍股...
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
变盘时刻
·
2024-10-22
$Ensysce Biosciences Inc.(ENSC)$
恭喜各位群友，这一单稍微操作，也有50%左右盈利，做了两次～
$特斯拉(TSLA)$
$思宏国际(NCI)$
$Genprex, Inc.(GNPX)$
$微软(MSFT)$
$Ensysce Biosciences Inc.(ENSC)$ 恭喜各位群友，这一单稍微操作，也有50%左右盈利，做了两次～ $特斯拉(TSLA)$ $...
精彩
山旎:
大佬，请教ENSC没走，0.5916成本，有救么
回复
5
点赞
6
编组 21备份 2
分享
举报
MECH
·
2024-10-23
$Ensysce Biosciences Inc.(ENSC)$
大家注意，这只股交易量惊人但是股价却低于全体平均成本了，说明游资在低位收筹码了，到时候又会是一波拉升，这只股十倍的历史又一次重演了，我先冲为敬了
$Ensysce Biosciences Inc.(ENSC)$ 大家注意，这只股交易量惊人但是股价却低于全体平均成本了，说明游资在低位收筹码了，到时候又...
回复
评论
点赞
1
编组 21备份 2
分享
举报
笵纳德.不靠谱
·
2024-10-22
$Ensysce Biosciences Inc.(ENSC)$
搞不搞的起来，不行的话我就有走了
$Ensysce Biosciences Inc.(ENSC)$ 搞不搞的起来，不行的话我就有走了
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
无敌站神
·
2024-10-22
$Ensysce Biosciences Inc.(ENSC)$
$Ensysce Biosciences Inc.(ENSC)$
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
Ensysce Biosciences Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.ensysce.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Ensysce Biosciences, Inc.于2003年4月在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。利用其胰蛋白酶激活滥用保护和多药滥用抗性平台，该公司正在开发一类新的强大、防篡改的阿片类药物，可防止药物滥用和过量服用。预计Ensysce的产品将提供更安全的选择来治疗严重的疼痛，并有助于预防阿片类药物滥用造成的死亡，从而降低人力和经济成本。
02-27
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
01-08
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-11-17
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-11-14
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-14
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-08-13
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-08-13
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-06-05
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-05-14
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-05-14
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-05-10
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2025-05-02
员工持股计划
Form S-8 - Securities to be offered to employees in employee benefit plans
Form S-8 - Securities to be offered to employees in employee benefit plans
2025-04-24
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
2025-04-24
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
2025-04-23
SEC问询函
Form CORRESP - Correspondence
Form CORRESP - Correspondence
分时
5日
日
周
月
数据加载中...
最高
0.5496
今开
0.5125
量比
0.01
最低
0.4900
昨收
0.5389
换手率
21.72%
热议股票
{"pagemeta":{"title":"Ensysce Biosciences Inc.(ENSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ensysce Biosciences Inc.(ENSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ensysce Biosciences Inc.,ENSC,Ensysce Biosciences Inc.股票,Ensysce Biosciences Inc.股票老虎,Ensysce Biosciences Inc.股票老虎国际,Ensysce Biosciences Inc.行情,Ensysce Biosciences Inc.股票行情,Ensysce Biosciences Inc.股价,Ensysce Biosciences Inc.股市,Ensysce Biosciences Inc.股票价格,Ensysce Biosciences Inc.股票交易,Ensysce Biosciences Inc.股票购买,Ensysce Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ensysce Biosciences Inc.(ENSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ensysce Biosciences Inc.(ENSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"ENSC","data":{"stockData":{"symbol":"ENSC","market":"US","secType":"STK","nameCN":"Ensysce Biosciences Inc.","latestPrice":0.5471,"timestamp":1772830800000,"preClose":0.5389,"halted":0,"volume":677561,"hourTrading":{"tag":"盘后","latestPrice":0.5362,"preClose":0.5471,"latestTime":"16:25 EST","volume":968,"amount":500.5378928,"timestamp":1772832306451,"change":-0.0109,"changeRate":-0.019923,"amplitude":0.056845},"delay":0,"changeRate":0.015216181109667814,"floatShares":3119300,"shares":3632307,"eps":-6.0968,"marketStatus":"盘后交易","change":0.0082,"latestTime":"03-06 16:42:20 EST","open":0.5125,"high":0.5496,"low":0.49,"amount":345228.305988,"amplitude":0.110596,"askPrice":0.5725,"askSize":100,"bidPrice":0.5211,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-6.0968,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1772845200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.5389,"preHourTrading":{"tag":"盘前","latestPrice":0.5277,"preClose":0.5389,"latestTime":"09:24 EST","volume":15698,"amount":8228.7173522,"timestamp":1772807080947,"change":-0.0112,"changeRate":-0.020783,"amplitude":0.048989},"postHourTrading":{"tag":"盘后","latestPrice":0.5362,"preClose":0.5471,"latestTime":"16:25 EST","volume":968,"amount":500.5378928,"timestamp":1772832306451,"change":-0.0109,"changeRate":-0.019923,"amplitude":0.056845},"volumeRatio":0.011238,"impliedVol":3.1521,"impliedVolPercentile":0},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.537348321253048","cardData":[{"tweetId":"537348321253048","author":{"authorId":"3557463925109250","idStr":"3557463925109250","name":"变盘时刻","avatar":"https://static.tigerbbs.com/2c826ba914279c42001048d7ddfa2372","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":3476,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"走势还不错，0.68 MARK<a href=\"https://laohu8.com/S/ENSC\">$Ensysce Biosciences Inc.(ENSC)$ </a>","plainDigest":"走势还不错，0.68 MARK$Ensysce Biosciences Inc.(ENSC)$ ","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1772207674658,"gmtModify":1772207959744,"symbols":["ENSC"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":497,"likeCount":2,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/537348321253048","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":53,"displayRows":4,"foldSize":0,"authorId":"3557463925109250"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.434985736478912","cardData":[{"tweetId":"434985736478912","author":{"authorId":"3575175745721611","idStr":"3575175745721611","name":"Tingli","avatar":"https://static.laohu8.com/default-avatar.jpg","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ENSC\">$Ensysce Biosciences Inc.(ENSC)$</a> 垃圾","plainDigest":"$Ensysce Biosciences Inc.(ENSC)$ 垃圾","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1747217022780,"gmtModify":1747218029198,"symbols":["ENSC"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":656,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/434985736478912","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":34,"displayRows":4,"foldSize":0,"authorId":"3575175745721611"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.382247902310784","cardData":[{"tweetId":"382247902310784","author":{"authorId":"3585687320157965","idStr":"3585687320157965","name":"Steven_Dai","avatar":"https://static.tigerbbs.com/f464a3d6a0544468f22ad29aaefbf14d","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":1,"wearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.02.06","exceedPercentage":"80.33%","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":48,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ENSC\">$Ensysce Biosciences Inc.(ENSC)$ </a> 搞起来啊","plainDigest":"$Ensysce Biosciences Inc.(ENSC)$ 搞起来啊","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1734366339119,"gmtModify":1734366340523,"symbols":["ENSC"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1650,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/382247902310784","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":38,"displayRows":4,"foldSize":0,"authorId":"3585687320157965"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.368469497729408","cardData":[{"tweetId":"368469497729408","author":{"authorId":"4095953544712430","idStr":"4095953544712430","name":"笵纳德.不靠谱","avatar":"https://static.tigerbbs.com/01437bbd2b303baf27945cf184bddced","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.26","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":84,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ENSC\">$Ensysce Biosciences Inc.(ENSC)$ </a> 艹，八毛进来挨毒打","plainDigest":"$Ensysce Biosciences Inc.(ENSC)$ 艹，八毛进来挨毒打","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1730995951764,"gmtModify":1730996863612,"symbols":["ENSC"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":1,"viewCount":2404,"likeCount":2,"liked":false,"collected":false,"commentCount":1,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/368469497729408","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":47,"displayRows":4,"foldSize":0,"authorId":"4095953544712430"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.366317696389320","cardData":[{"tweetId":"366317696389320","author":{"authorId":"4095953544712430","idStr":"4095953544712430","name":"笵纳德.不靠谱","avatar":"https://static.tigerbbs.com/01437bbd2b303baf27945cf184bddced","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.26","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":84,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ENSC\">$Ensysce Biosciences Inc.(ENSC)$ </a> 是不是要完犊子了，74进来就这个样子","plainDigest":"$Ensysce Biosciences Inc.(ENSC)$ 是不是要完犊子了，74进来就这个样子","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1730474662521,"gmtModify":1730475583071,"symbols":["ENSC"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1188,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/366317696389320","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":63,"displayRows":4,"foldSize":0,"authorId":"4095953544712430"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.365766859870336","cardData":[{"tweetId":"365766859870336","author":{"authorId":"3575412473386063","idStr":"3575412473386063","name":"我就赚一个小目标","avatar":"https://static.tigerbbs.com/b1516a301f200e2b95c297797052643a","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[],"fanSize":11,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ENSC\">$Ensysce Biosciences Inc.(ENSC)$</a> 又一支<a href=\"https://laohu8.com/S/DRUG\">$Bright Minds Biosciences Inc(DRUG)$</a> 20倍股 50倍？你选吧","plainDigest":"$Ensysce Biosciences Inc.(ENSC)$ 又一支$Bright Minds Biosciences Inc(DRUG)$ 20倍股 50倍？你选吧","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1730298974160,"gmtModify":1730298976242,"symbols":["ENSC","DRUG"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":4036,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/365766859870336","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":86,"displayRows":4,"foldSize":0,"authorId":"3575412473386063"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.362771410010248","cardData":[{"tweetId":"362771410010248","author":{"authorId":"3557463925109250","idStr":"3557463925109250","name":"变盘时刻","avatar":"https://static.tigerbbs.com/2c826ba914279c42001048d7ddfa2372","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":3476,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ENSC\">$Ensysce Biosciences Inc.(ENSC)$</a> 恭喜各位群友，这一单稍微操作，也有50%左右盈利，做了两次～ <a href=\"https://laohu8.com/S/TSLA\">$特斯拉(TSLA)$ </a> <a href=\"https://laohu8.com/S/NCI\">$思宏国际(NCI)$</a> <a href=\"https://laohu8.com/S/GNPX\">$Genprex, Inc.(GNPX)$</a> <a href=\"https://laohu8.com/S/MSFT\">$微软(MSFT)$ </a> ","plainDigest":"$Ensysce Biosciences Inc.(ENSC)$ 恭喜各位群友，这一单稍微操作，也有50%左右盈利，做了两次～ $特斯拉(TSLA)$ $思宏国际(NCI)$ $Genprex, Inc.(GNPX)$ $微软(MSFT)$","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1729603903033,"gmtModify":1729609762250,"symbols":["ENSC","NCI","TSLA","MSFT","GNPX"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"popularizeThemeFlag":false,"imageCount":3,"images":[{"url":"https://static.tigerbbs.com/9741f3bc428c62824ab4b14a8b3a8c52","width":"696","height":"1122"},{"url":"https://static.tigerbbs.com/ea31e5597a6fb7ef9f86f60e8fc9a067","width":"696","height":"1122"},{"url":"https://static.tigerbbs.com/592395f92c14ddead75be5ef58ca806e","width":"1260","height":"2800"}],"repostCount":0,"viewCount":6659,"likeCount":6,"liked":false,"collected":false,"commentCount":5,"hotComments":[{"id":"363139851010256","author":{"authorId":"3481573272067925","idStr":"3481573272067925","name":"山旎","avatar":"https://static.tigerbbs.com/cb79fbfe069e3f980989ae066aaeb7f2","userType":1,"introduction":"","crmLevel":4,"crmLevelSwitch":1,"fanSize":5,"starInvestorFlag":false},"content":"大佬，请教ENSC没走，0.5916成本，有救么","plainContent":"大佬，请教ENSC没走，0.5916成本，有救么","likeCount":0,"commentType":"valid","coins":0},{"id":"362955953397968","author":{"authorId":"3557463925109250","idStr":"3557463925109250","name":"变盘时刻","avatar":"https://static.tigerbbs.com/2c826ba914279c42001048d7ddfa2372","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"fanSize":3476,"starInvestorFlag":false},"content":"标记：第三弹微亏，第四弹FAMI赚回来了，对冲掉我就不晒单了","plainContent":"标记：第三弹微亏，第四弹FAMI赚回来了，对冲掉我就不晒单了","likeCount":0,"commentType":"valid","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/362771410010248","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":144,"displayRows":4,"foldSize":0,"authorId":"3557463925109250"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.363126760833160","cardData":[{"tweetId":"363126760833160","author":{"authorId":"4182980128824982","idStr":"4182980128824982","name":"MECH","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","userType":1,"introduction":"","crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":12,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ENSC\">$Ensysce Biosciences Inc.(ENSC)$</a> 大家注意，这只股交易量惊人但是股价却低于全体平均成本了，说明游资在低位收筹码了，到时候又会是一波拉升，这只股十倍的历史又一次重演了，我先冲为敬了","plainDigest":"$Ensysce Biosciences Inc.(ENSC)$ 大家注意，这只股交易量惊人但是股价却低于全体平均成本了，说明游资在低位收筹码了，到时候又会是一波拉升，这只股十倍的历史又一次重演了，我先冲为敬了","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1729679418956,"gmtModify":1729679538429,"symbols":["ENSC"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":4686,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/363126760833160","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":169,"displayRows":4,"foldSize":0,"authorId":"4182980128824982"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.362759299219736","cardData":[{"tweetId":"362759299219736","author":{"authorId":"4095953544712430","idStr":"4095953544712430","name":"笵纳德.不靠谱","avatar":"https://static.tigerbbs.com/01437bbd2b303baf27945cf184bddced","userType":1,"introduction":"","crmLevel":1,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.26","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"fanSize":84,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ENSC\">$Ensysce Biosciences Inc.(ENSC)$ </a> 搞不搞的起来，不行的话我就有走了","plainDigest":"$Ensysce Biosciences Inc.(ENSC)$ 搞不搞的起来，不行的话我就有走了","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1729605716990,"gmtModify":1729605718335,"symbols":["ENSC"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":1092,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/362759299219736","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":61,"displayRows":4,"foldSize":0,"authorId":"4095953544712430"}],"position":0},{"cardType":"TWEET","cardId":"TWEET.362833269780560","cardData":[{"tweetId":"362833269780560","author":{"authorId":"3573208751041700","idStr":"3573208751041700","name":"无敌站神","avatar":"https://static.tigerbbs.com/737f57a205317ab48ac795bffc3a0c19","userType":1,"introduction":"","crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"digest":"<a href=\"https://laohu8.com/S/ENSC\">$Ensysce Biosciences Inc.(ENSC)$ </a> ","plainDigest":"$Ensysce Biosciences Inc.(ENSC)$","sourceLanguage":"EN","currentLanguage":"EN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1729604870637,"gmtModify":1729605257006,"symbols":["ENSC"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/b85dc378e6aa1fa83dc9fd1e98432910","width":"978","height":"1668"}],"repostCount":0,"viewCount":2249,"likeCount":0,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/362833269780560","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":30,"displayRows":4,"foldSize":0,"authorId":"3573208751041700"}],"position":0}],"size":10},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"20778120","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315226008343-ENSC","pdf_url":"","pub_time":1772168400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ENSC","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226008343/0001493152-26-008343-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226008343/form8-k.htm","primary":true,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILE2tPmiraXtzYniLz3","market":"us","size":42186}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-02-27 13:00","pubTimestamp":1772168400,"title_zh":"Form 8-K - Current report","summary_en":"Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing","summary_zh":"第3.01项：除牌通知或未能符合持续上市规则或标准；转让上市","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20617000","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315226000994-ENSC","pdf_url":"","pub_time":1767848400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ENSC","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226000994/0001493152-26-000994-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315226000994/form8-k.htm","primary":true,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILEHZjDie8YePUAno1e","market":"us","size":49517}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-01-08 13:00","pubTimestamp":1767848400,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","summary_zh":"项目5.07：将事项提交证券持有人表决","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20421269","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315225023933-ENSC","pdf_url":"","pub_time":1763355600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ENSC","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023933/0001493152-25-023933-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-4.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023933/ex4-1.htm","primary":true,"translateUrl":"","linkName":"ex4-1.htm","type":"EX-4.1","id":"NTFILE4ZfAspXSvCZ8UQZe","market":"us","size":247166},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023933/form8-k.htm","primary":false,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILE5jNzX8XexYC36MaG","market":"us","size":72334},{"description":"EX-4.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023933/ex4-2.htm","primary":false,"translateUrl":"","linkName":"ex4-2.htm","type":"EX-4.2","id":"NTFILE6dabMDdVT76BFRxW","market":"us","size":140078},{"description":"EX-5.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023933/ex5-1.htm","primary":false,"translateUrl":"","linkName":"ex5-1.htm","type":"EX-5.1","id":"NTFILE87K6tZfLCrg3vb4t","market":"us","size":23094},{"description":"EX-10.1","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023933/ex10-1.htm","primary":false,"translateUrl":"","linkName":"ex10-1.htm","type":"EX-10.1","id":"NTFILE9FKwUAX74mispXrJ","market":"us","size":302157},{"description":"EX-99.1","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023933/ex99-1.htm","primary":false,"translateUrl":"","linkName":"ex99-1.htm","type":"EX-99.1","id":"NTFILE4Sjs8gnhPT4V25KB","market":"us","size":14218},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023933/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEErS8xkLa7DsMoWdP","market":"us","size":3989}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-17 13:00","pubTimestamp":1763355600,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记的股本证券销售；第5.03项：公司章程或章程的修订；财政年度的变化；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20414192","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315225023498-ENSC","pdf_url":"","pub_time":1763096400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"ENSC","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023498/0001493152-25-023498-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023498/form10-q.htm","primary":true,"translateUrl":"","linkName":"form10-q.htm","type":"10-Q","id":"NTFILECkaxXmnTCf7rqVex","market":"us","size":1035908},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023498/ex31-1.htm","primary":false,"translateUrl":"","linkName":"ex31-1.htm","type":"EX-31.1","id":"NTFILE5D2GEJ6ja7a7r9k3","market":"us","size":18466},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023498/ex31-2.htm","primary":false,"translateUrl":"","linkName":"ex31-2.htm","type":"EX-31.2","id":"NTFILEDf6JC5Lp3qJHY2Sg","market":"us","size":18513},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023498/ex32-1.htm","primary":false,"translateUrl":"","linkName":"ex32-1.htm","type":"EX-32.1","id":"NTFILE9AuDPxNJiEnxXXDy","market":"us","size":8031},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023498/ex32-2.htm","primary":false,"translateUrl":"","linkName":"ex32-2.htm","type":"EX-32.2","id":"NTFILEAwfUTt71SchTCjBE","market":"us","size":7994}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-11-14 13:00","pubTimestamp":1763096400,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20414176","market":"us","labels":[],"media":"sec.gov","original_id":"AN149315225023492-ENSC","pdf_url":"","pub_time":1763096400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ENSC","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023492/0001493152-25-023492-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023492/ex99-1.htm","primary":true,"translateUrl":"","linkName":"ex99-1.htm","type":"EX-99.1","id":"NTFILE6uGHR6cFSFDncBid","market":"us","size":63331},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000149315225023492/form8-k.htm","primary":false,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILEGaeHGPWEGwDrkqT3","market":"us","size":45061}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-11-14 13:00","pubTimestamp":1763096400,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19982481","market":"us","labels":[],"media":"sec.gov","original_id":"AN164117225023500-ENSC","pdf_url":"","pub_time":1755057600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ENSC","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225023500/0001641172-25-023500-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225023500/ex99-1.htm","primary":true,"translateUrl":"","linkName":"ex99-1.htm","type":"EX-99.1","id":"NTFILEtyZjBJZmL6sH4GBN","market":"us","size":115026},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225023500/form8-k.htm","primary":false,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILEAYquuRox84KinoTk","market":"us","size":40424}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-08-13 12:00","pubTimestamp":1755057600,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第2.02项：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19982471","market":"us","labels":[],"media":"sec.gov","original_id":"AN164117225023512-ENSC","pdf_url":"","pub_time":1755057600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"ENSC","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225023512/0001641172-25-023512-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225023512/form10-q.htm","primary":true,"translateUrl":"","linkName":"form10-q.htm","type":"10-Q","id":"NTFILEJ9u1AyaxmP4Rmvsa","market":"us","size":1129919},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225023512/ex31-1.htm","primary":false,"translateUrl":"","linkName":"ex31-1.htm","type":"EX-31.1","id":"NTFILE6FjppknceKXdvugJ","market":"us","size":19087},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225023512/ex31-2.htm","primary":false,"translateUrl":"","linkName":"ex31-2.htm","type":"EX-31.2","id":"NTFILE2RgwQNdiYmb6qZxf","market":"us","size":18951},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225023512/ex32-1.htm","primary":false,"translateUrl":"","linkName":"ex32-1.htm","type":"EX-32.1","id":"NTFILEFngkS4Hzi2HsQRZD","market":"us","size":8553},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225023512/ex32-2.htm","primary":false,"translateUrl":"","linkName":"ex32-2.htm","type":"EX-32.2","id":"NTFILEHK9cxjMVbzXGqdYj","market":"us","size":8255}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-08-13 12:00","pubTimestamp":1755057600,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19740200","market":"us","labels":[],"media":"sec.gov","original_id":"AN164117225013853-ENSC","pdf_url":"","pub_time":1749096000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ENSC","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225013853/0001641172-25-013853-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-16.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225013853/ex16-1.htm","primary":true,"translateUrl":"","linkName":"ex16-1.htm","type":"EX-16.1","id":"NTFILE71BBdacXPfkxh22j","market":"us","size":3829},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225013853/form8-k.htm","primary":false,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILEBvt2w4QXuqp5oELm","market":"us","size":35257}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-06-05 12:00","pubTimestamp":1749096000,"title_zh":"Form 8-K - Current report","summary_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第4.01项：注册人注册会计师的变更；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19639177","market":"us","labels":[],"media":"sec.gov","original_id":"AN164117225009955-ENSC","pdf_url":"","pub_time":1747167632000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"ENSC","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1716947/0001641172-25-009955-index.html","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225009955/form10-q.htm","primary":true,"translateUrl":"","linkName":"form10-q.htm","type":"10-Q","id":"NTFILEHCXxYQG8uaz8pixi","market":"us","size":883553},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225009955/ex31-1.htm","primary":false,"translateUrl":"","linkName":"ex31-1.htm","type":"EX-31.1","id":"NTFILEDERZQ6w7YiqZAvGf","market":"us","size":18835},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225009955/ex31-2.htm","primary":false,"translateUrl":"","linkName":"ex31-2.htm","type":"EX-31.2","id":"NTFILE9u32gCroaZ8CiLed","market":"us","size":18912},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225009955/ex32-1.htm","primary":false,"translateUrl":"","linkName":"ex32-1.htm","type":"EX-32.1","id":"NTFILE42XpZqd4mt5Bzi2X","market":"us","size":8565},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225009955/ex32-2.htm","primary":false,"translateUrl":"","linkName":"ex32-2.htm","type":"EX-32.2","id":"NTFILE9RRDeaUfN1zuwKAG","market":"us","size":8430}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-05-14 04:20","pubTimestamp":1747167632,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19639210","market":"us","labels":[],"media":"sec.gov","original_id":"AN164117225009949-ENSC","pdf_url":"","pub_time":1747167312000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ENSC","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1716947/0001641172-25-009949-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225009949/ex99-1.htm","primary":true,"translateUrl":"","linkName":"ex99-1.htm","type":"EX-99.1","id":"NTFILE6D2ZZsfKBPKcp4tf","market":"us","size":56244},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225009949/form8-k.htm","primary":false,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILEBShndGjR9k8NgMvi","market":"us","size":37910}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-05-14 04:15","pubTimestamp":1747167312,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目2.02：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19758362","market":"us","labels":[],"media":"sec.gov","original_id":"AN164117225009386-ENSC","pdf_url":"","pub_time":1746810043000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"ENSC","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1716947/0001641172-25-009386-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225009386/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE9dxZPRCeyXbByAPe","market":"us","size":13382}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-05-10 01:00","pubTimestamp":1746810043,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19595754","market":"us","labels":[],"media":"sec.gov","original_id":"AN164117225008392-ENSC","pdf_url":"","pub_time":1746158400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 - Securities to be offered to employees in employee benefit plans","symbol":"ENSC","title":"Form S-8 - Securities to be offered to employees in employee benefit plans","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225008392/0001641172-25-008392-index.htm","us_notice_code":"Form S-8","us_title_en":"Form S-8 - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225008392/forms-8.htm","primary":true,"translateUrl":"","linkName":"forms-8.htm","type":"S-8","id":"NTFILE4teuuho7D4rMMvnB","market":"us","size":93256},{"description":"EX-5","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225008392/ex5.htm","primary":false,"translateUrl":"","linkName":"ex5.htm","type":"EX-5","id":"NTFILE5Kr4wZkG9NaYi4ds","market":"us","size":14645},{"description":"EX-23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225008392/ex23-1.htm","primary":false,"translateUrl":"","linkName":"ex23-1.htm","type":"EX-23.1","id":"NTFILEDFfz49ixpPJnB5va","market":"us","size":4090},{"description":"CALCULATION OF FILING FEE TABLES","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225008392/ex107.htm","primary":false,"translateUrl":"","linkName":"ex107.htm","type":"EX-FILING FEES","id":"NTFILE8NEhyvppuEHSYwUR","market":"us","size":14520},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225008392/ex5_001.jpg","primary":false,"translateUrl":"","linkName":"ex5_001.jpg","type":"GRAPHIC","id":"NTFILE9K7DAENnUKyXeqk3","market":"us","size":10393}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2025-05-02 12:00","pubTimestamp":1746158400,"title_zh":"Form S-8 - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19491137","market":"us","labels":[],"media":"sec.gov","original_id":"AN164117225006009-ENSC","pdf_url":"","pub_time":1745467200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ENSC","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225006009/0001641172-25-006009-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"null","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225006009/ex4-1.htm","primary":true,"translateUrl":"","linkName":"ex4-1.htm","type":"EX-4.1","id":"NTFILEHbbDgSdChuSeE8tn","market":"us","size":135853},{"description":"null","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225006009/form8-k.htm","primary":false,"translateUrl":"","linkName":"form8-k.htm","type":"8-K","id":"NTFILEATHSPg42WRk2mAqG","market":"us","size":44050},{"description":"null","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225006009/ex4-2.htm","primary":false,"translateUrl":"","linkName":"ex4-2.htm","type":"EX-4.2","id":"NTFILEA1dNtL2WcePgXkWU","market":"us","size":113397},{"description":"null","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225006009/ex10-1.htm","primary":false,"translateUrl":"","linkName":"ex10-1.htm","type":"EX-10.1","id":"NTFILEFsqF8bhk7zTReT7J","market":"us","size":61399},{"description":"null","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225006009/ex99-1.htm","primary":false,"translateUrl":"","linkName":"ex99-1.htm","type":"EX-99.1","id":"NTFILEJ1QeComdjDAL72aL","market":"us","size":15339}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-04-24 12:00","pubTimestamp":1745467200,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记的股本证券销售；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19679797","market":"us","labels":[],"media":"sec.gov","original_id":"AN164117225005799-ENSC","pdf_url":"","pub_time":1745425366000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"ENSC","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1716947/0001641172-25-005799-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225005799/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE5gP9Fx2pD7bpoYRG","market":"us","size":14622}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-04-24 00:22","pubTimestamp":1745425366,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19685149","market":"us","labels":[],"media":"sec.gov","original_id":"AN164117225005657-ENSC","pdf_url":"","pub_time":1745346083000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"ENSC","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1716947/0001641172-25-005657-index.html","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1716947/000164117225005657/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEB8KiQLz8vmNxk4fm","market":"us","size":12556}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-04-23 02:21","pubTimestamp":1745346083,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.ensysce.com","stockEarnings":[{"period":"1week","weight":0.3643},{"period":"1month","weight":-0.1161},{"period":"3month","weight":-0.6714},{"period":"6month","weight":-0.7476},{"period":"1year","weight":-0.8945},{"period":"ytd","weight":-0.4142}],"compareEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.0119},{"period":"3month","weight":-0.0064},{"period":"6month","weight":0.0526},{"period":"1year","weight":0.1685},{"period":"ytd","weight":-0.0009}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ensysce Biosciences, Inc.于2003年4月在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。利用其胰蛋白酶激活滥用保护和多药滥用抗性平台，该公司正在开发一类新的强大、防篡改的阿片类药物，可防止药物滥用和过量服用。预计Ensysce的产品将提供更安全的选择来治疗严重的疼痛，并有助于预防阿片类药物滥用造成的死亡，从而降低人力和经济成本。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.065355},{"month":2,"riseRate":0.125,"avgChangeRate":-0.163567},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.109375},{"month":4,"riseRate":0.25,"avgChangeRate":-0.051395},{"month":5,"riseRate":0.5,"avgChangeRate":-0.125258},{"month":6,"riseRate":0.75,"avgChangeRate":0.040392},{"month":7,"riseRate":0.375,"avgChangeRate":-0.146088},{"month":8,"riseRate":0.25,"avgChangeRate":-0.103132},{"month":9,"riseRate":0.5,"avgChangeRate":-0.126709},{"month":10,"riseRate":0.375,"avgChangeRate":0.059933},{"month":11,"riseRate":0.5,"avgChangeRate":-0.054799},{"month":12,"riseRate":0.625,"avgChangeRate":0.113688}],"exchange":"NASDAQ","name":"Ensysce Biosciences Inc.","nameEN":"Ensysce Biosciences Inc."},"aProfile":null}}}